196 related articles for article (PubMed ID: 7911069)
1. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters.
Odagiri E; Kanada N; Jibiki K; Demura R; Aikawa E; Demura H
Cancer; 1994 Jun; 73(12):2978-84. PubMed ID: 7911069
[TBL] [Abstract][Full Text] [Related]
2. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
4. c-erbB-2 amplification in node-negative human breast cancer.
Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G
Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2 and c-erbA-1 (ear-1) gene amplification and c-erbB-2 protein expression in Japanese breast cancers: their relationship to the histology and other disease parameters.
Uehara T; Kaneko Y; Kanda N; Yamamoto T; Higashi Y; Nomoto C; Izumo T; Takayama S; Sakurai M
Jpn J Cancer Res; 1990; 81(6-7):620-4. PubMed ID: 1976118
[TBL] [Abstract][Full Text] [Related]
6. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.
Tsuda H; Iwaya K; Fukutomi T; Hirohashi S
Jpn J Cancer Res; 1993 Apr; 84(4):394-401. PubMed ID: 8099903
[TBL] [Abstract][Full Text] [Related]
8. Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.
Yamada Y; Yoshimoto M; Murayama Y; Ebuchi M; Mori S; Yamamoto T; Sugano H; Toyoshima K
Jpn J Cancer Res; 1989 Dec; 80(12):1192-8. PubMed ID: 2576425
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary studies on c-erbB-2 protooncogene in breast cancer].
He LW
Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):171-4. PubMed ID: 1356719
[TBL] [Abstract][Full Text] [Related]
11. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer.
Babiak J; Hugh J; Poppema S
Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701
[TBL] [Abstract][Full Text] [Related]
12. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
[TBL] [Abstract][Full Text] [Related]
13. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance.
Guérin M; Gabillot M; Mathieu MC; Travagli JP; Spielmann M; Andrieu N; Riou G
Int J Cancer; 1989 Feb; 43(2):201-8. PubMed ID: 2563719
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 amplification in breast cancer: detection in formalin-fixed, paraffin-embedded tissue by in situ hybridization.
Smith KL; Robbins PD; Dawkins HJ; Papadimitriou JM; Redmond SL; Carrello S; Harvey JM; Sterrett GF
Hum Pathol; 1994 Apr; 25(4):413-8. PubMed ID: 7909307
[TBL] [Abstract][Full Text] [Related]
16. [int-2 and c-erbB-2 gene amplification in urological cancers].
Sato K; Kato T; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
19. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene.
Tsuda H; Tsugane S; Fukutomi T; Nanasawa T; Yamamoto H; Hirohashi S
Jpn J Clin Oncol; 1992 Aug; 22(4):244-9. PubMed ID: 1359174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
